AI assistant
Merck & Co., Inc. — Director's Dealing 2018
Jan 19, 2018
284_dirs_2018-01-19_17e274af-b89e-4697-abcd-f4b828fea15f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-01-12
Reporting Person: GRADDICK WEIR MIRIAN M (Exe V-P, HR)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-12 | Common Stock | S | 8000.0000 | $58.0000 | Disposed | 98484.3190 | Direct |
| 2018-01-16 | Common Stock | M | 52000.0000 | $44.3000 | Acquired | 150484.3190 | Direct |
| 2018-01-16 | Common Stock | S | 8000.0000 | $61.6300 | Disposed | 142484.3190 | Direct |
| 2018-01-16 | Common Stock | S | 52000.0000 | $61.6300 | Disposed | 90484.3190 | Direct |
Footnotes
F1: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
F2: The original Form 4, filed on January 16, 2018, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 12, 2018 as a total of 5,000 shares sold when in fact 8,000 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 3,000 shares, and includes shares acquired in dividend reinvestment transactions.
F3: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.